原发性肝癌肉瘤与肉瘤样癌的临床及影像学对比
回顾性分析17例肝癌肉瘤(CS)与27例肉瘤样癌(SC)的临床及影像资料,SC组年龄更高且淋巴结受累更常见;增强后CS组延迟期多呈部分或完全廓清,SC组多呈持续或渐进性强化,差异有统计学意义(P=0.042)。
要点
- SC组淋巴结受累约半数,显著高于CS组(P=0.023)。
- 延迟期CS多呈部分或完全廓清,SC多呈持续或渐进强化(P=0.042)。
- 两组动脉期均呈不均匀强化,CS强化见于边缘及实性成分,SC见于边缘及分隔。
核心结论
- SC组年龄和淋巴结受累显著高于CS组;CS组增强以延迟期廓清或部分廓清为主,SC组以延迟期持续或渐进性强化为主。
研究设计与样本
- 回顾性分析2010年9月至2024年12月本院经手术或穿刺活检诊断的17例CS和27例SC患者的临床及影像数据。
关键影像表现/征象
- 两组多位于右肝叶,肿瘤较大、常单发、形态不规则、分叶状,多数伴坏死和出血。
- CT上CS组有2例见钙化。
- 两组肿瘤边缘多不清晰,多数无包膜。
- SC组约半数有淋巴结受累,显著高于CS组(P=0.023)。
- 增强动脉期两组均呈不均匀强化;CS组强化多位于边缘和实性成分,SC组多位于边缘和分隔。
临床应用与阅片要点
- 延迟期出现部分或完全廓清时,影像上更支持CS。
- 延迟期呈持续或渐进性强化时,影像上更支持SC。
- 发现淋巴结受累时,影像上更支持SC。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Primary liver carcinosarcoma (CS) and sarcomatoid carcinoma (SC) are rare malignant tumors of the liver. Although the two tumors often overlap in clinical and imaging manifestations, there are currently no reports comparing the imaging features of these two tumors. Our study aims to compare the clinical characteristics and imaging features of these two tumors to further describe their distinct features, thereby enhancing understanding and diagnostic accuracy.
METHODS: A retrospective analysis was conducted on the clinical and imaging data of 17 patients with CS and 27 patients with SC diagnosed by surgical or needle biopsy between September 2010 and December 2024 at our hospital. The data were summarized and statistically analyzed.
RESULTS: Both groups were predominantly male, with a lower mean age (56.65 ± 11.82) in the CS group compared to the SC group (64.93 ± 8.15) (P = 0.01). Compared to the SC group, the CS group more commonly presented with hepatitis B, cirrhosis, and elevated AFP levels. Both groups were more commonly located in the right hepatic lobe, with larger tumors that were often solitary, irregularly shaped, and lobulated. Most tumors exhibited necrosis and hemorrhage. Calcification was observed in two cases in the CS group on CT scans. The tumor margins were predominantly indistinct, and the majority of tumors did not show a capsule. Approximately half of the patients in the SC group had lymph node involvement, which was significantly higher than in the CS group (P = 0.023). After contrast enhancement, all cases in both groups showed heterogeneous enhancement in the arterial phase. Regarding enhancement distribution, the CS group more commonly exhibited enhancement at the margins and in the solid components, while most cases in the SC group showed enhancement at the margins and in the septa. In terms of dynamic enhancement patterns, the CS group more commonly exhibited partial or complete regression in the delayed phase, while the SC group more commonly exhibited progressive or persistent enhancement in the delayed phase, with statistical significance (P = 0.042).
CONCLUSION: Patients in the SC group had significantly higher age and lymph node involvement than those in the CS group. In terms of tumor enhancement patterns, the CS group primarily exhibited delayed-phase regression or partial regression, while the SC group primarily exhibited delayed-phase persistent or progressive enhancement.
引用
- Lu L, Zhang R, Pan X, et al. Clinical and imaging comparison of primary liver carcinosarcoma and sarcomatoid carcinoma. Abdom Radiol (NY). 2025. PMID: 40848125. doi:10.1007/s00261-025-05156-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。